1. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Issue 6 (June 2021) Authors: Frangoul, Haydar; Altshuler, David; Cappellini, M. Domenica; Chen, Yi-Shan; Domm, Jennifer; Eustace, Brenda K.; Foell, Juergen; de la Fuente, Josu; Grupp, Stephan; Handgretinger, Rupert; Ho, Tony W.; Kattamis, Antonis; Kernytsky, Andrew; Lekstrom-Himes, Julie; Li, Amanda M.; Locatelli, Franco; Ma... Journal: Obstetrical & gynecological survey Issue: Volume 76:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials. Issue 11 (21st October 2014) Authors: Matulonis, Ursula A.; Oza, Amit M.; Ho, Tony W.; Ledermann, Jonathan A. Journal: Cancer Issue: Volume 121:Issue 11(2015) Page Start: 1737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐Term Open‐Label Safety Study of Rizatriptan Acute Treatment in Pediatric Migraineurs. Issue 1 (18th October 2012) Authors: Hewitt, David J.; Pearlman, Eric; Hämäläinen, Mirja; Lewis, Donald; Connor, Kathryn M.; Michelson, David; Ceesay, Paulette; Assaid, Christopher; Bachman, Robert; Harper Mozley, Lyn; Dupre, Nicole; Strickler, Nancy; Mahoney, Erin; Lines, Christopher; Ho, Tony W. Journal: Headache Issue: Volume 53:Issue 1(2013) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗